Research Progress of Potential Drug Target PARP16
Author:
Affiliation:

1)College of Rehabilitation, Gannan Medical University, Ganzhou 341000, China;2)College of Pharmaceutical Sciences, Gannan Medical University, Ganzhou 341000, China;3)First Affiliated Hospital of Gannan Medical University, Ganzhou 341000, China;4)Dayu Counity People Hospital, Ganzhou 341500, China;5)School of Basic Medical Sciences, Nanchang University,Nanchang 330031, China

Clc Number:

Fund Project:

This work was supported by grants from The National Natural Science Foundation of China (81402850, 21961003), Natural Science Foundation of Jiangxi Province (20192BAB205114), “Double Thousand Plan” in JiangXi Province (Jxsq2018106059, Jxsq2019101064), Jiangxi Key Research and Development Plan Program (20203BBG73063).

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    PARP16 is a momo-ADP ribotransferase belonging to the members of the poly(ADP-ribose) poiyerases (PARPs) family, unlike other family members, it is an anchored transmembrane protein located in the endoplasmic reticulum. During the unfolding protein reaction of the endoplasmic reticulum, the two pressure sensors PERK and IRE1α of the endoplasmic reticulum will be activated, and PARP16 plays an important role in this process.Through their single ADP-ribosylation and activating biological activity, PARP16 can regulate cancer, cardiovascular diseases and cystic fibrosis, which make it become a great potential drug target for major human diseases such as cancer and cardiovascular disease. This article mainly describes the structures and function of PARP16, related diseases mediated, and small molecule inhibitors.

    Reference
    Related
    Cited by
Get Citation

WU Jian-Le, LU Xiao-Lu, BIAN Shui-Gen, ZHU Jin-Mei, ZHANG Jin, JIANG Feng, LI Jian. Research Progress of Potential Drug Target PARP16[J]. Progress in Biochemistry and Biophysics,2022,49(3):553-560

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:April 19,2021
  • Revised:June 04,2021
  • Accepted:June 08,2021
  • Online: March 21,2022
  • Published: March 20,2022